Consortium direct and F&A are both a direct cost to the main applicant.  Your institution should apply your indirect cost rate to the first 25K of a subcontract regardless of whether it is direct or F&A cost. 

 

I penned this explanation for our ERA programmers:

 

The only thing different about subcontractor IDC is that

 

1) it does not influence the calculation of NIH modules,

2) it does not count against the direct cost maximum for an NIH program and

3) NIH wants us to leave it out of the direct cost total we show on the face page for these purposes;

 

however, it is still part of the MTDC base when calculating indirect costs (< 25K) and still part of the total direct costs for a proposal.

 

Robert Aull

Indiana University School of Medicine

 

-----Original Message-----
From: Research Administration List [mailto:xxxxxx@HRINET.ORG] On Behalf Of McKinley, Brenda
Sent: Monday, May 23, 2005 3:24 PM
To: xxxxxx@HRINET.ORG
Subject: Re: [RESADM-L] NIH Modular Grants

 

Folks,

 

While we are on the topic of NIH grants with Consortium F&A, I have a question that I have not been able to find an answer for...

 

Our indirect cost base includes the first $25K of any subcontract.  Would our institution still be able to charge indirect costs on the consortium F&A included in the first $25K?  I can't find where NIH guidelines state they will not pay indirect costs on consortium F&A.

 

Thanks for the input.

 

Brenda McKinley

 

 

 


From: Research Administration List [mailto:xxxxxx@HRINET.ORG] On Behalf Of Blake, Valerie
Sent: Monday, May 23, 2005 2:29 PM
To: xxxxxx@HRINET.ORG
Subject: Re: [RESADM-L] NIH Modular Grants

Hello Leesa,

You would include your consortium F&A in 7b and 8b.

Valerie

 

Valerie A. Blake
Assistant Director
North Shore-Long Island Jewish Health System
Office of Grants and Contracts
5 Dakota Drive, Suite 307
Lake Success, NY  11042
Tel:  (516) 719-3100
Fax: (516) 719-3110
xxxxxx@nshs.edu

 

-----Original Message-----
From: Research Administration List [mailto:xxxxxx@HRINET.ORG]On Behalf
Of Pamela Miller
Sent: Monday, May 23, 2005 1:32 PM
To: xxxxxx@HRINET.ORG
Subject: [RESADM-L] NIH Modular Grants

 

I am passing this question on from a colleague at Seattle University:

Question re: NIH modular grant:

Now that the  consortium F & A is separate from the direct costs on the
budget justification page, where do we include the consortium F & A on
the cover sheet?  Would it be included in the direct costs in 7a and 8a
or would we include the consortium F & A in the total costs in 7b and
8b?

Thank you for your help!

 

Leesa Brown
Sponsored Research Officer
Seattle University
206-296-6161

 

Pamela F. Miller, Ph.D.
Director, Office of Sponsored Projects
The University of San Francisco
2130 Fulton Street
San Francisco, CA  94117-1080
TEL  415-422-5368
FAX  415-422-6222
EMAIL  xxxxxx@usfca.edu

 

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================
_____________________________________________________________________

The information contained in this electronic e-mail transmission
and any attachments are intended only for the use of the individual
or entity to whom or to which it is addressed, and may contain
information that is privileged, confidential and exempt from
disclosure under applicable law. If the reader of this communication
is not the intended recipient, or the employee or agent responsible
for delivering this communication to the intended recipient, you
are hereby notified that any dissemination, distribution, copying
or disclosure of this communication and any attachment is strictly
prohibited. If you have received this transmission in error, please
notify the sender immediately by telephone and electronic mail,
and delete the original communication and any attachment from any
computer, server or other electronic recording or storage device
or medium. Receipt by anyone other than the intended recipient is
not a waiver of any attorney-client, physician-patient or other
privilege. Thank you.

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================

====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================